Fasting Time Effects in Time-Restricted Eating (FaTE-TRE)

Last updated: April 22, 2021
Sponsor: University of Padova
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diet And Nutrition

Treatment

N/A

Clinical Study ID

NCT04503005
FaTE-TRE
  • Ages 18-60
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Over the past century, lifestyles and eating habits have rapidly changed, helping to increase the onset of conditions such as obesity, metabolic syndrome and the risk of cardiovascular and metabolic diseases such as diabetes.

Recently, dietary regimens such as calorie restriction and intermittent fasting have been promoted as new strategies for reducing obesity and related co-morbidities. These strategies have proven effective in reducing body fat, improving blood pressure, lipid profile and insulin resistance in overweight individuals. However, due to the rigidity of these food protocols, the adherence of subjects to the diet is often limited or maintained only for short periods.

Time-Restricted Eating (TRE) is a less extreme form of intermittent fasting, in which the subject's daily calorie intake is consumed only in a certain period of time during the day (normally 8-12 hours). TRE have been able to reduce fat mass, pro-inflammatory markers (eg IL-6, TNF-a) and have improved some biomarkers related to cardiovascular risks (eg Insulin, HDL, TG).

The literature offers numerous versions of intermittent fasting, and the role of fasting duration is not yet fully clear. Thus. the aim of the present study is to investigate the effect od different duration of fasting in a TRE protocol on body composition and lipid and inflammatory profile. Moreover, the study intended to explore the effect of 2 month of TRE on long term maintenance of diet habits, body composition, lipid and inflammatory profile.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • BMI between 18-30 kg/m2
  • Stable body weight for at least 3 months

Exclusion

Exclusion Criteria:

  • type 2 Diabetes or pre-diabetes for ADA guidelines
  • Significant Chronic disease
  • recent and acute inflammatory status
  • Recent (within 3 months) treatment with anabolic steroids, systemic corticosteroids orestrogen.
  • regular exercise training (≥ 2 sessions/week) or ≥ 10,000 steps/day

Study Design

Total Participants: 40
Study Start date:
March 08, 2021
Estimated Completion Date:
August 31, 2022

Connect with a study center

  • Nutrition and Exercise Lab, DSB, University of Padova

    Padova, 35131
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.